top of page
Browse by category
Search


Surgery effective for substantial weight loss after GLP-1 intolerance or limited weight loss
A Cleveland Clinic study has found that people with obesity who do not tolerate the weight-loss medications semaglutide or tirzepatide, or who do not lose enough weight with the medications, can achieve substantial weight loss after bariatric surgery. Ali Aminian (Credit: Cleveland Clinic) “GLP-1 medications have transformed obesity care, but they don’t work for everyone,” said Dr Ali Aminian, director of Cleveland Clinic’s Bariatric and Metabolic Institute, and lead author o
Browse by tag






bottom of page
